Virax Biolabs Group Limited (VRAX) Ownership
VRAX ownership summary
as of October 18, 2026- Institutions
- 2.0% of shares outstanding
- Insiders
- 1.58% of shares outstanding
- Shares outstanding
- 1.3M
- Float
- 529K shares available to trade
- Short interest
- 0.50% 6,645 shares short
- Days to cover
- 0.19 short interest down 78.2% vs prior month
- Institutions 1.99%
- Insiders 1.58%
- Other investors 96.43%
VRAX top institutional holders
8 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Jane Street Group LLC | 1.96% | 26K | $38,258 | +26,385 (0.0%) | June 30, 2026 |
| 2 | UBS Group AG | <0.01% | 4 | $6 | +4 (0.0%) | June 30, 2026 |
| 3 | NATIONAL BANK OF CANADA /FI/ | 0.00% | — | — | −6,000 (−100.0%) | March 31, 2026 |
| 4 | Jump Financial LLC | 0.00% | — | — | −1,629 (−100.0%) | June 30, 2026 |
| 5 | Armistice Capital, LLC | 0.00% | — | — | −35,152 (−100.0%) | June 30, 2026 |
| 6 | Advisor Group Holdings, Inc. | 0.00% | — | — | −1 (−100.0%) | June 30, 2026 |
| 7 | XTX Topco Ltd | 0.00% | — | — | −21,437 (−100.0%) | March 31, 2026 |
| 8 | Northwestern Mutual Wealth Management Co | 0.00% | — | — | −10 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 8, 2 holders added 26K shares and 6 cut 64K.
VRAX top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.01% | 542 | $786 | — | March 31, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
VRAX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VRAX
Institutional investors own 2.0% of Virax Biolabs's shares and insiders 1.58%. The largest holder is Jane Street Group LLC with 1.96% of the shares (26K), as of June 30, 2026. Among the top 8 institutions, 2 added shares and 6 reduced their stake in the latest filings. Short interest is 0.50% of the float, or 0.19 days of average trading volume. The share count fell 58.1% since 2019.
Related: VRAX analyst forecast, VRAX key metrics. See the VRAX stock overview for the latest quote and news.
VRAX ownership FAQ
Who owns the most Virax Biolabs stock?
The largest shareholders of Virax Biolabs are Jane Street Group LLC (1.96%), UBS Group AG (<0.01%), NATIONAL BANK OF CANADA /FI/ (0.00%), Jump Financial LLC (0.00%), Armistice Capital, LLC (0.00%).
What percentage of Virax Biolabs is owned by institutions?
Institutions hold 2.0% of Virax Biolabs's shares outstanding; insiders hold 1.58%.
Which funds own Virax Biolabs?
The largest fund holders of Virax Biolabs are Fidelity Nasdaq Composite Index (0.01%).
What is Virax Biolabs's short interest?
6,645 shares of Virax Biolabs were sold short, 0.50% of the float; at the average daily volume it would take 0.19 days to cover.
How many shares of Virax Biolabs are outstanding?
Virax Biolabs has 1.3M shares outstanding, of which 529K are in the public float.